Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-19

Clinical Trial Update: Myocardial Protection of Exenatide in AMI [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating whether exenatide provides myocardial protection in acute myocardial infarction. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED